U.S. Pharmaceutical Contract Manufacturing and Research Services Market Size is USD 78.44 Billion in 2026

U.S. Pharmaceutical Contract Manufacturing and Research Services Market (By Service: Manufacturing and Research) Industry Size, Share, Growth, Trends 2026 to 2035.

Report Code : 789 | Published : 15 May 2026 | Delivery : Immediate | Format : Excel | Author : Aditi Shivarkar, Aman Singh

Revenue,

USD 74 Bn

Forecast Year,

USD 132.52 Bn

CAGR, 2026 - 2035

6.00%

Report Coverage

U.S.

Download Databook

The U.S. pharmaceutical contract manufacturing and research services market is projected to grow from USD 74 billion in 2025 to USD 132.52 billion by 2035, registering a CAGR of 6% due to rising outsourcing activities, expanding drug development pipelines, and increasing demand for cost-efficient manufacturing solutions.

U.S. Pharmaceutical Contract Manufacturing and Research Services Market Statical Scope

Reports Attributes	Statistics
Market Size in 2025	USD 74 Billion
Market Size in 2026	USD 78.44 Billion
Market Size by 2035	USD 132.52 Billion
CAGR 2026 to 2035	6%
Base Year	2025
Forecast Period	2026 to 2035

The expanding investment in cell, gene, and specialty therapies is driving demand for outsourced pharmaceutical contract manufacturing and clinical research services.

Pharmaceutical companies are focusing on improving operational flexibility, reducing infrastructure costs, and accelerating drug development and commercialization timelines. The rising investment in cell and gene therapies , mRNA technologies, and advanced manufacturing facilities is supporting market expansion.

The adoption of artificial intelligence (AI) and decentralized clinical trial models by contract research organisations with a robust biotechnology ecosystem, which rely on outsourcing Research and development, also contributes to market growth.

Segments	Shares (%)
Manufacturing	64%
Research	36%

Manufacturing - Manufacturing leads the segment, with a share of 64%, driven by strong outsourcing demand from pharmaceutical companies for large-scale production, advanced production infrastructure, and regulatory-compliant manufacturing capabilities. Pharmaceutical companies are increasingly relying on contract manufacturers to support large scale production and manage rising development costs.
Research - Research follows, with a share of 36%, supported by extensive pharmaceutical innovation, increasing outsourcing of drug discovery, rising clinical trial activities, and early-stage development activities to specialized service providers. Drug developers are outsourcing research operations to accelerate product development timelines.

Top Companies in the U.S. Pharmaceutical Contract Manufacturing and Research Services Market

Catalent, Inc (Novo Holdings A/S)
PPD (Thermo Fisher Scientific Inc.)
AbbVie Inc.
Advent International, L.P.
Grifols
Dalton Pharma Services
Boehringer Ingelheim International GmbH
Lonza

Segments Covered in the Report

By Service

Manufacturing
- API/Bulk Drugs
- Advanced Drug Delivery Formulations
- Packaging
- Finished Dose Formulations
- Solid
- Liquid
- Semi-solid Formulations
Research
- Oncology
- Vaccines
- Inflammation & Immunology
- Cardiology
- Neuroscience
- Others

List of Tables & Figures

List of Tables

Table 1: U.S. Pharmaceutical Contract Manufacturing and Research Services Market Size, 2025-2035 (USD Billion)
Table 2: U.S. Pharmaceutical Contract Manufacturing and Research Services Market Size, by Service, 2025-2035 (USD Billion)
Table 3: U.S. Pharmaceutical Manufacturing Services Market Size, 2025-2035 (USD Billion)
Table 4: U.S. Pharmaceutical Research Services Market Size, 2025-2035 (USD Billion)
Table 5: U.S. Pharmaceutical Contract Manufacturing Market Share, by Service, 2025-2035 (USD Billion)
Table 6: U.S. Pharmaceutical Contract Research Market Share, by Service, 2025-2035 (USD Billion)
Table 7: U.S. Pharmaceutical Contract Manufacturing and Research Services Market Revenue Analysis, 2025-2035 (USD Billion)
Table 8: U.S. Pharmaceutical Manufacturing Services Revenue Forecast, 2025-2035 (USD Billion)
Table 9: U.S. Pharmaceutical Research Services Revenue Forecast, 2025-2035 (USD Billion)
Table 10: U.S. Pharmaceutical Contract Manufacturing and Research Services Market Growth Analysis, 2025-2035 (USD Billion)
Table 11: U.S. Pharmaceutical Contract Manufacturing and Research Services Market Trends Analysis, 2025-2035
Table 12: U.S. Pharmaceutical Manufacturing Services Market Opportunity Analysis, 2025-2035
Table 13: U.S. Pharmaceutical Research Services Market Opportunity Analysis, 2025-2035
Table 14: U.S. Pharmaceutical Contract Manufacturing and Research Services Market Competitive Benchmarking, 2025
Table 15: U.S. Pharmaceutical Contract Manufacturing and Research Services Market Company Share Analysis, 2025
Table 16: U.S. Pharmaceutical Manufacturing Services Market Regional Revenue Insights, 2025-2035 (USD Billion)
Table 17: U.S. Pharmaceutical Research Services Market Regional Revenue Insights, 2025-2035 (USD Billion)
Table 18: U.S. Pharmaceutical Contract Manufacturing and Research Services Market Strategic Developments, 2025-2035
Table 19: U.S. Pharmaceutical Contract Manufacturing and Research Services Market Investment Analysis, 2025-2035 (USD Billion)
Table 20: U.S. Pharmaceutical Contract Manufacturing and Research Services Market Forecast Summary, 2025-2035 (USD Billion)

List of Figures

Figure 1: U.S. Pharmaceutical Contract Manufacturing and Research Services Market Forecast, 2025-2035 (USD Billion)
Figure 2: U.S. Pharmaceutical Contract Manufacturing and Research Services Market Share, by Service, 2025 (%)
Figure 3: U.S. Pharmaceutical Manufacturing Services Market Forecast, 2025-2035 (USD Billion)
Figure 4: U.S. Pharmaceutical Research Services Market Forecast, 2025-2035 (USD Billion)
Figure 5: U.S. Pharmaceutical Contract Manufacturing and Research Services Market Growth Trend, 2025-2035 (%)
Figure 6: U.S. Pharmaceutical Contract Manufacturing and Research Services Market Opportunity Map, 2025-2035 (% CAGR)
Figure 7: U.S. Pharmaceutical Manufacturing Services Revenue Share, 2025 (%)
Figure 8: U.S. Pharmaceutical Research Services Revenue Share, 2025 (%)
Figure 9: U.S. Pharmaceutical Contract Manufacturing and Research Services Competitive Landscape, 2025 (%)
Figure 10: U.S. Pharmaceutical Contract Manufacturing and Research Services Market Strategic Insights, 2025-2035

Research Methodology

Related Databooks

March 2026